Ms Contin

   
Google
 
Web NewDrugInformation.com

Ms Contin


Drug - Ms Contin
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Morphine Sulfate
Multiple ingredients are in alphabetical order.

Strength - 60MG
The potency of the active ingredient(s), Morphine Sulfate. May repeat for multiple part products.

Applicant - PURDUE FREDERICK
The firm name holding legal responsibility for Ms Contin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019516
The FDA assigned number to Ms Contin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Ms Contin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 8, 1988
The date Ms Contin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Ms Contin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ms Contin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Purdue Frederick Co
The full name of the firm holding legal responsibility for the new application of Ms Contin.

Ms Contin